Degarelix treatment is compatible with diabetes and antithrombotic therapy in patients with prostate cancer

Degarelix treatment is compatible with diabetes and antithrombotic therapy in patients with prostate cancer

Suguru Tokiwa,1 Hiroaki Shimmura,1 Shuhei Nomura,2–4 Ryota Watanabe,1 Minoru Kurita,1 Naoto Yoshida,1 Kaori Yamashita,1 Yoshitaka Nishikawa,5 Alexander Kouzmenko,6 Shigeaki Kato4 1Department of Urology, Jyoban Hospital, Tokiwa Foundation, Iwaki, Fukushima, Japan; 2Department of Epidemiolog...

Full description

Bibliographic Details
Main Authors: Tokiwa S, Shimmura H, Nomura S, Watanabe R, Kurita M, Yoshida N, Yamashita K, Nishikawa Y, Kouzmenko A, Kato S
Format: Article
Language:English
Published: Dove Medical Press 2017-12-01
Series:Research and Reports in Urology
Subjects:
GnRH antagonists
Prostate cancer
Degarelix
Discontinuation
Diabetes
Antithrombotic treatment
Online Access:https://www.dovepress.com/degarelix-treatment-is-compatible-with-diabetes-and-antithrombotic-the-peer-reviewed-article-RRU

Internet

https://www.dovepress.com/degarelix-treatment-is-compatible-with-diabetes-and-antithrombotic-the-peer-reviewed-article-RRU

Similar Items